Dr Subodh Kumar

Employment

• Post Graduate Institute of Medical Education and Research

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (53)

• Viral Oncology
  CRC Press 2025 DOI: 10.1201/9781003516651
  +Save
• A randomised controlled trial to evaluate the effectiveness of a culture and disease-specific, patient-centric multi-component tobacco cessation intervention package for the patients attending non-communicable disease clinics in Punjab, India
  Psychology & Health 2025 DOI: 10.1080/08870446.2024.2333896
  +Save
• An insight into the simulation directed understanding of the mechanism in SARS CoV-2 N-CTD, dimer integrity, and RNA-binding: Identifying potential antiviral inhibitors
  Journal of Biomolecular Structure and Dynamics 2022 DOI: 10.1080/07391102.2021.1996463
  +Save
• Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors “leflunomide” and “teriflunomide” in Covid-19: A narrative review
  European Journal of Pharmacology 2021 DOI: 10.1016/j.ejphar.2021.174233
  +Save
• Indian contribution toward biomedical research and development in COVID-19: A systematic review
  Indian Journal of Pharmacology 2021 DOI: 10.4103/ijp.ijp_168_21
  +Save
• Current practices in oncology drug delivery
  Advanced Drug Delivery Systems in the Management of Cancer 2021 DOI: 10.1016/b978-0-323-85503-7.00006-7
  +Save
• Efficacy and Safety of Topical Cysteamine in Corneal Cystinosis: A Systematic Review and Meta-Analysis
  American Journal of Ophthalmology 2021 DOI: 10.1016/j.ajo.2020.07.052
  +Save
• Current status of in silico, preclinical and clinical study registries across the globe: A systematic review and meta-analysis.
  Indian journal of pharmacology 2021 DOI: 10.4103/ijp.ijp_1090_20
  +Save
• Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
  Medical Hypotheses 2021 DOI: 10.1016/j.mehy.2021.110539
  +Save
• Everolimus: A potential therapeutic agent targeting PI3K/Akt pathway in brain insulin system dysfunction and associated neurobehavioral deficits
  Fundamental & Clinical Pharmacology 2021 DOI: 10.1111/fcp.12677
  +Save